Stay updated on Nivolumab-Daratumumab Combo in Advanced Cancers Clinical Trial

Sign up to get notified when there's something new on the Nivolumab-Daratumumab Combo in Advanced Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab-Daratumumab Combo in Advanced Cancers Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Added Naples, Italy, 80131 to the listed locations and removed Napoli, Italy, 80131.
    Difference
    0.0%
    Check dated 2026-03-25T21:45:47.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-18T19:33:46.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-11T18:16:40.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the prior v3.4.1 notice about government funding and operating status was removed, with no changes to the study details or participant information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T02:40:32.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Added a government funding status notice at the top of the page. Updated the page revision from v3.4.0 to v3.4.1 and removed the previous revision note.
    Difference
    0.4%
    Check dated 2026-02-04T00:00:21.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option to provide term definitions. Updated QC-related labels and revision notes (including 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0') and removed older variants ('Last Update Submitted that met QC Criteria', 'No FEAR Act data', 'Revision: v3.3.4').'
    Difference
    0.2%
    Check dated 2026-01-28T00:16:05.000Z thumbnail image

Stay in the know with updates to Nivolumab-Daratumumab Combo in Advanced Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab-Daratumumab Combo in Advanced Cancers Clinical Trial page.